Summit Securities Group’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-232
Closed -$4.13K 1164
2025
Q1
$4.13K Buy
+232
New +$4.13K ﹤0.01% 492
2024
Q2
Sell
-251
Closed -$4K 585
2024
Q1
$4K Buy
+251
New +$4K ﹤0.01% 250
2019
Q2
Hold
0
190
2019
Q1
Hold
0
186
2018
Q4
Hold
0
190